Revvity, Inc
As on 02 Jul, 2025 | 01:29 IST
| Open | 96.22 |
| Previous Close | 96.72 |
| Beta | 0.66 |
| High | 102.18 |
| Low | 96.26 |
| TTM EPS See historical trend | 4.93(+6.71% YoY) |
| 52 Week High | 129.01 |
| 52 Week Low | 87.71 |
| TTM PE See historical trend | 20.08(Average PE) |
| Mkt. Cap ($ Billion) | 12.23 |
| Dividend Yield | 0.26 |
Advanced Chart
*Delayed by 20 seconds.
MC Technicals
| Days | |
|---|---|
| 5 | 98.1 |
| 10 | 96.57 |
| 20 | 95.12 |
| 50 | 93.52 |
| 100 | 101.5 |
| 200 | 110.16 |
Returns
| 1 Week | 4.17% | |
| 1 Month | 9.38% | |
| 3 Months | -6.33% | |
| YTD | -11.27% | |
| 1 Year | -5.42% | |
| 3 Years | -30.39% |
Financialsin million $
Peers
| Name | Price ($) | Change% | M.Cap(Billion $) | TTM PE | TTM EPS | DY | 52 wk high/low | Technical Rating | |
|---|---|---|---|---|---|---|---|---|---|
| Thermo Fisher Scientific | 538.92 | 0.40 | 205.43 | 24.61 | 21.89 | 0.41 | 610.77/385.72 | 14.06 | Very Bullish |
| Intuitive Surgical | 446.13 | 2.65 | 158.07 | 55.40 | 8.05 | -- | 614.58/427.84 | 2.84 | Very Bearish |
| Danaher | 209.13 | -0.85 | 150.95 | 27.75 | 7.53 | 0.59 | 275.43/171.26 | 8.49 | Neutral |
| Edwards Lifesciences | 74.62 | 2.71 | 45.53 | 29.69 | 2.60 | -- | 95.25/58.97 | -1.22 | Very Bullish |
| Agilent | 141.92 | 0.58 | 34.35 | 22.30 | 5.40 | 0.85 | 153.84/96.45 | 7.61 | Very Bullish |
Market news
- Wall Street sells off as Trump hits China with more tariffsOctober 11, 2025 8:32 AM
- Dow, S&P 500 manage record closing highs; Nasdaq falls in volatile sessionOctober 4, 2025 9:34 AM
- Wall Street closes higher, boosted by healthcare as investors shrug off jobs data, US shutdownOctober 2, 2025 8:05 AM
- Wall Street ends streak of weekly gains, yields rise as investors digest dataSeptember 27, 2025 8:50 AM
About the company
PerkinElmer, Inc. is a provider of products, services and solutions for the diagnostics, life sciences and applied markets. The Company operates through two segments: Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment provides products and services targeted towards the life sciences and applied markets. The Diagnostics segment develops diagnostics, tools and applications focused on clinically oriented customers, especially within the reproductive health, immunodiagnostics and applied genomics markets. The Company provides early detection for genetic disorders from pregnancy to early childhood, and infectious disease testing for the diagnostics market. It offers its products under various brand names, including AutoDELFIA, BACS-on-Beads, BIOCHIPs, Bioo Scientific, BoBs, chemagic, Chitas, Datalytix, DELFIA, DELFIA Xpress, DOPlify, EONIS, EUROArray, EUROIMMUN, EUROLabWorkstation, EUROline, EUROPattern, FragilEase, Genoglyphix, GSP, and Haoyuan.